Search

Search Results
Results 611 - 620 of 780 for Male breast cancer
  • News - 25 Jul 2005
    Fragile X-associated tremor/ataxia syndrome can be difficult to diagnose and should have guidelines for diagnostic testing, according to a study in the July 26 issue of Neurology, the scientific...
  • News - 19 Jun 2025
    Gene expression, where cells use the genetic information encoded in DNA to produce proteins, has been thought of as a dimmer light.
  • News - 25 Feb 2025
    A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG).
  • Drug - 24 Feb 2025
    Consumer Medicine Information (CMI) about Gardasil 9 intended for persons living in Australia.
  • News - 5 Feb 2025
    By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia - a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles.
  • Drug - 29 Jan 2025
    Consumer Medicine Information (CMI) about Pomalyst intended for persons living in Australia.
  • Drug - 23 Jan 2025
    Consumer Medicine Information (CMI) about Revlimid intended for persons living in Australia.
  • Drug - 6 Jan 2025
    Consumer Medicine Information (CMI) about Alecensa intended for persons living in Australia.
  • Drug - 22 Oct 2024
    Consumer Medicine Information (CMI) about Tafinlar intended for persons living in Australia.
  • Drug - 15 Oct 2024
    Consumer Medicine Information (CMI) about Proquad intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.